Northwest Biotherapeutics Inc (NWBO)
0.2901
0.00 (0.00%)
USD |
OTCM |
Nov 14, 15:59
Northwest Biotherapeutics Total Assets (Quarterly): 28.22M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 28.22M |
| March 31, 2024 | 28.57M |
| December 31, 2023 | 27.86M |
| September 30, 2023 | 31.49M |
| June 30, 2023 | 28.44M |
| March 31, 2023 | 32.87M |
| December 31, 2022 | 31.32M |
| September 30, 2022 | 31.10M |
| June 30, 2022 | 27.52M |
| March 31, 2022 | 30.66M |
| December 31, 2021 | 40.16M |
| September 30, 2021 | 28.22M |
| June 30, 2021 | 28.77M |
| March 31, 2021 | 32.46M |
| December 31, 2020 | 32.90M |
| September 30, 2020 | 27.21M |
| June 30, 2020 | 14.91M |
| March 31, 2020 | 9.183M |
| December 31, 2019 | 10.64M |
| September 30, 2019 | 10.14M |
| June 30, 2019 | 14.70M |
| March 31, 2019 | 24.47M |
| December 31, 2018 | 24.67M |
| September 30, 2018 | 46.33M |
| June 30, 2018 | 48.48M |
| Date | Value |
|---|---|
| March 31, 2018 | 49.78M |
| December 31, 2017 | 48.91M |
| September 30, 2017 | 49.75M |
| June 30, 2017 | 47.38M |
| March 31, 2017 | 48.31M |
| December 31, 2016 | 52.91M |
| September 30, 2016 | 48.94M |
| June 30, 2016 | 51.61M |
| March 31, 2016 | 62.23M |
| December 31, 2015 | 70.80M |
| September 30, 2015 | 51.64M |
| June 30, 2015 | 64.25M |
| March 31, 2015 | 49.41M |
| December 31, 2014 | 56.46M |
| September 30, 2014 | 29.39M |
| June 30, 2014 | 12.58M |
| March 31, 2014 | 12.51M |
| December 31, 2013 | 18.78M |
| September 30, 2013 | 7.635M |
| June 30, 2013 | 2.437M |
| March 31, 2013 | 0.521M |
| December 31, 2012 | 7.57M |
| September 30, 2012 | 0.428M |
| June 30, 2012 | 1.018M |
| March 31, 2012 | 0.226M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.183M
Minimum
Mar 2020
40.16M
Maximum
Dec 2021
27.50M
Average
28.57M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.72M |
| Shareholders Equity (Quarterly) | -76.50M |
| Debt to Equity Ratio | -0.6672 |
| Current Ratio | 0.0886 |
| Net Debt Paydown Yield | -0.93% |